Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

April 01, 2008 (Vol. 28, No. 7)

Cancer Biomarkers Expedite Detection

But Validation Must Be Improved to Obtain Truly Accurate Diagnostic Tools

  • It is widely acknowledged that early detection is the key to successful cancer treatment, yet such aggressive intervention requires accurate screening tools. Traditional diagnostic tests for cancer have a number of drawbacks including poor sensitivity, lack of specificity, and costly and invasive protocols. Now, finally, a variety of new biomarkers ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.